LTI
JAZZ icon

Laffer Tengler Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Laffer Tengler Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,450
Closed -$1.43M – 178
2025
Q2 		$1.43M Buy
+13,450
New +$1.46M 0.25% 91
2024
Q4 		– Sell
-13,450
Closed -$1.5M – 157
2024
Q3 		$1.5M Hold
13,450
– – 0.3% 85
2024
Q2 		$1.44M Buy
+13,450
New +$1.48M 0.31% 89

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Laffer Tengler Investments's JAZZ Position: Q3 2025 in Review

Laffer Tengler Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 13,450 shares — an estimated $1.43M sold.

Laffer Tengler Investments first reported a position in JAZZ in Q2 2024 and held it in 3 quarters. The position peaked at $1.5M in Q3 2024. 502 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Laffer Tengler Investments reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Laffer Tengler Investments sold 13,450 Jazz Pharmaceuticals shares in Q3 2025, an estimated $1.43M.
  • Laffer Tengler Investments first reported a position in Jazz Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Laffer Tengler Investments's Jazz Pharmaceuticals position peaked at $1.5M in Q3 2024.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Laffer Tengler Investments's 13F filing for Q3 2025, filed 12 Nov 2025.